Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
Open | $11.900 |
Close | $10.520 |
Volume / Avg. | 83.996K / 26.906K |
Day Range | 9.500 - 11.900 |
52 Wk Range | 3.800 - 18.526 |
Market Cap | $80.454M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 1.14% |
Days to Cover | 4.78 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Other companies in Curis’s space includes: Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO), Eagle Pharmaceuticals (NASDAQ:EGRX), CollPlant Biotechnologies (NASDAQ:CLGN) and MAIA Biotechnology (AMEX:MAIA).
The latest price target for Curis (NASDAQ: CRIS) was reported by Truist Securities on Wednesday, May 15, 2024. The analyst firm set a price target for 26.00 expecting CRIS to rise to within 12 months (a possible 90.48% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Curis (NASDAQ: CRIS) is $13.65 last updated May 16, 2024 at 8:03 AM EDT.
There are no upcoming dividends for Curis.
Curis’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.